CervoMed Inc. (NASDAQ: CRVO) reported Q3 EPS of ($0.70), $2.23 better than the analyst estimate of ($2.93). Revenue for the quarter came in at $1.52 million.

For earnings history and earnings-related data on CervoMed Inc. (CRVO) click here.